133 related articles for article (PubMed ID: 14729159)
1. Perinatal changes of brain-derived neurotrophic factor in pre- and fullterm neonates.
Malamitsi-Puchner A; Economou E; Rigopoulou O; Boutsikou T
Early Hum Dev; 2004 Jan; 76(1):17-22. PubMed ID: 14729159
[TBL] [Abstract][Full Text] [Related]
2. Intrauterine growth restriction and circulating neurotrophin levels at term.
Malamitsi-Puchner A; Nikolaou KE; Economou E; Boutsikou M; Boutsikou T; Kyriakakou M; Puchner KP; Hassiakos D
Early Hum Dev; 2007 Jul; 83(7):465-9. PubMed ID: 17071024
[TBL] [Abstract][Full Text] [Related]
3. Determinants of brain-derived neurotrophic factor (BDNF) in umbilical cord and maternal serum.
Flöck A; Weber SK; Ferrari N; Fietz C; Graf C; Fimmers R; Gembruch U; Merz WM
Psychoneuroendocrinology; 2016 Jan; 63():191-7. PubMed ID: 26460781
[TBL] [Abstract][Full Text] [Related]
4. The varying patterns of neurotrophin changes in the perinatal period.
Nikolaou KE; Malamitsi-Puchner A; Boutsikou T; Economou E; Boutsikou M; Puchner KP; Baka S; Hassiakos D
Ann N Y Acad Sci; 2006 Dec; 1092():426-33. PubMed ID: 17308169
[TBL] [Abstract][Full Text] [Related]
5. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.
Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D
Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100
[TBL] [Abstract][Full Text] [Related]
6. BRAIN-DERIVED NEUROTROPHIC FACTOR: DIAGNOSTIC PERSPECTIVE IN NEONATES WITH GESTATIONAL AGE LESS THAN 34 WEEKS.
Kyslova I; Yablon O; Mazulov O; Savrun T; Bykovska O
Georgian Med News; 2018 Dec; (285):41-46. PubMed ID: 30702068
[TBL] [Abstract][Full Text] [Related]
7. Placental and cord blood brain derived neurotrophic factor levels are decreased in nondiabetic macrosomia.
Cai QY; Zhang HX; Wang CC; Sun H; Sun SQ; Wang YH; Yan HT; Yang XJ
Arch Gynecol Obstet; 2017 Aug; 296(2):205-213. PubMed ID: 28589478
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor and ciliary neurotrophic factor in maternal plasma and umbilical cord blood from pre-eclamptic and physiological pregnancies.
Bienertova-Vasku J; Bienert P; Zlamal F; Splichal Z; Tomandl J; Tomandlova M; Hodicka Z; Ventruba P; Vasku A
J Obstet Gynaecol; 2013 May; 33(4):359-63. PubMed ID: 23654315
[TBL] [Abstract][Full Text] [Related]
9. Effects of maternal smoking and exposure to methylmercury on brain-derived neurotrophic factor concentrations in umbilical cord serum.
Spulber S; Rantamäki T; Nikkilä O; Castrén E; Weihe P; Grandjean P; Ceccatelli S
Toxicol Sci; 2010 Oct; 117(2):263-9. PubMed ID: 20631062
[TBL] [Abstract][Full Text] [Related]
10. Selenium concentrations in maternal and umbilical cord blood at 24-42 weeks of gestation: basis for optimization of selenium supplementation to premature infants.
Makhoul IR; Sammour RN; Diamond E; Shohat I; Tamir A; Shamir R
Clin Nutr; 2004 Jun; 23(3):373-81. PubMed ID: 15158301
[TBL] [Abstract][Full Text] [Related]
11. Perinatal serum bone Gla-protein and vitamin D metabolites in preterm and fullterm neonates.
Delmas PD; Glorieux FH; Delvin EE; Salle BL; Melki I
J Clin Endocrinol Metab; 1987 Sep; 65(3):588-91. PubMed ID: 3497940
[TBL] [Abstract][Full Text] [Related]
12. Perinatal changes of circulating N-terminal pro B-type natriuretic peptide (NT-proBNP) in normal and intrauterine-growth-restricted pregnancies.
Iacovidou N; Briana DD; Boutsikou M; Gourgiotis D; Baka S; Vraila VM; Hassiakos D; Malamitsi-Puchner A
Hypertens Pregnancy; 2007; 26(4):463-71. PubMed ID: 18066964
[TBL] [Abstract][Full Text] [Related]
13. Differences in brain-derived neurotrophic factor between neonates born to mothers with normal and low ferritin.
Yusrawati ; Rina G; Indrawati LN; Machmud R
Asia Pac J Clin Nutr; 2018; 27(2):389-392. PubMed ID: 29384327
[TBL] [Abstract][Full Text] [Related]
14. Effect of maternal iron deficiency anemia on fetal neural development.
Basu S; Kumar D; Anupurba S; Verma A; Kumar A
J Perinatol; 2018 Mar; 38(3):233-239. PubMed ID: 29234149
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-2 in the perinatal period and the role of intrauterine growth restriction.
Malamitsi-Puchner A; Boutsikou T; Economou E; Tzonou A; Makrakis E; Nikolaou KE; Hassiakos D
Acta Obstet Gynecol Scand; 2006; 85(1):45-8. PubMed ID: 16521679
[TBL] [Abstract][Full Text] [Related]
16. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.
Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143
[TBL] [Abstract][Full Text] [Related]
17. Antenatal steroid exposure in the late preterm period is associated with reduced cord blood neurotrophin-3.
Hodyl NA; Crawford TM; McKerracher L; Lawrence A; Pitcher JB; Stark MJ
Early Hum Dev; 2016 Oct; 101():57-62. PubMed ID: 27411106
[TBL] [Abstract][Full Text] [Related]
18. Changes in neurotrophin levels in umbilical cord blood from infants with different gestational ages and clinical conditions.
Chouthai NS; Sampers J; Desai N; Smith GM
Pediatr Res; 2003 Jun; 53(6):965-9. PubMed ID: 12621105
[TBL] [Abstract][Full Text] [Related]
19. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period.
Malamitsi-Puchner A; Protonotariou E; Boutsikou T; Makrakis E; Sarandakou A; Creatsas G
Early Hum Dev; 2005 Apr; 81(4):387-92. PubMed ID: 15814224
[TBL] [Abstract][Full Text] [Related]
20. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.
Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A
Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
